New Breakthrough in Cancer Research Shows Promising Results

A team of medical researchers at the University of Oxford has announced a major breakthrough in cancer treatment. A newly developed immunotherapy drug has successfully trained the human immune system to target and destroy advanced cancer cells without harming healthy tissue.</p> <p class="mb-4 leading-relaxed">In phase-one clinical trials involving 150 patients, the drug demonstrated an impressive 85% success rate in halting tumor progression. Unlike traditional chemotherapy, patients experienced minimal side effects, such as mild fatigue and headache.</p> <p class="mb-4 leading-relaxed">Lead scientist Dr. Sarah Jenkins described the results as a 'turning point' in oncology. The team is currently preparing for larger phase-two trials, with hopes of securing FDA approval by the end of 2028.